Kristina Miger, Anne Sophie Overgaard Olesen, Johannes Grand, Olav W Nielsen
{"title":"Prognostic Pathways in Acute Dyspnoea: Differentiating Intravascular from Extravascular Congestion in the Emergency Department.","authors":"Kristina Miger, Anne Sophie Overgaard Olesen, Johannes Grand, Olav W Nielsen","doi":"10.1093/ehjacc/zuaf147","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf147","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Why do guidelines ignore the management of Type-2 Myocardial Infarction?","authors":"Harvey D White","doi":"10.1093/ehjacc/zuaf138","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf138","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F A Klok, Andrew Sharp, Ingo Ahrens, Milica Aleksic, Fionnuala Ni Ainle, Stefano Barco, Laurent Bertoletti, Brent Keeling, Karl Fengler, Julie Helms, David Jiménez, Irene M Lang, Mandy N Lauw, Roberto Lorusso, Ignacio Martin-Loeches, Lilian J Meijboom, Nicolas Meneveau, Jose Montero-Cabezas, Gerry O'Sullivan, Roberto Pola, Piotr Pruszczyk, Olivier Sanchez, Oliver Schlager, Jacob Schultz, Umit Yasar Sinan, Maria Cristina Vedovati, Peter Verhamme, Ahmed Zaher, Menno V Huisman, S V Konstantinides
Patients with acute pulmonary embolism (PE) may present with cardiac arrest, overt or impending cardiogenic shock and/or severe respiratory insufficiency. Immediate evaluation and management of these patients require high clinical suspicion along with (bedside) imaging to confirm the diagnosis, targeted haemodynamic and/or respiratory support, appropriate anticoagulant treatment, and in many cases reperfusion therapy. The immediate treatment decision-making is largely driven by local expertise and resources and should be guided by the individual patient's characteristics such as cardiopulmonary comorbidities, risk of bleeding and location, extent and hemodynamic impact of the clot. Over the past years, treatment options for patients with severe PE have expanded substantially. For instance, several new catheter-guided reperfusion therapies have emerged and experience with circulatory mechanical support has increased. Along with the rise of new interventional therapies has come the introduction of expert multidisciplinary pulmonary embolism (EXPERT-PE) care teams, composed of multidisciplinary specialists involved in treating severe acute PE. This model of care provides a platform for rapid decisions on individualized treatment strategies, combining expert opinion from all involved specialties, setting the quality standards for modern local and regional equity PE care, and forming the base for future research in this area. Clinical decisions should be evidence-based where possible, and incorporate the individual patient's and their carer's preferences, values, and priorities, as well as those of the managing clinicians and care team. In this review, we summarize the evidence for the introduction of EXPERT-PE care teams and provide a practical manual for their successful implementation.
{"title":"Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team.","authors":"F A Klok, Andrew Sharp, Ingo Ahrens, Milica Aleksic, Fionnuala Ni Ainle, Stefano Barco, Laurent Bertoletti, Brent Keeling, Karl Fengler, Julie Helms, David Jiménez, Irene M Lang, Mandy N Lauw, Roberto Lorusso, Ignacio Martin-Loeches, Lilian J Meijboom, Nicolas Meneveau, Jose Montero-Cabezas, Gerry O'Sullivan, Roberto Pola, Piotr Pruszczyk, Olivier Sanchez, Oliver Schlager, Jacob Schultz, Umit Yasar Sinan, Maria Cristina Vedovati, Peter Verhamme, Ahmed Zaher, Menno V Huisman, S V Konstantinides","doi":"10.1093/ehjacc/zuaf141","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf141","url":null,"abstract":"<p><p>Patients with acute pulmonary embolism (PE) may present with cardiac arrest, overt or impending cardiogenic shock and/or severe respiratory insufficiency. Immediate evaluation and management of these patients require high clinical suspicion along with (bedside) imaging to confirm the diagnosis, targeted haemodynamic and/or respiratory support, appropriate anticoagulant treatment, and in many cases reperfusion therapy. The immediate treatment decision-making is largely driven by local expertise and resources and should be guided by the individual patient's characteristics such as cardiopulmonary comorbidities, risk of bleeding and location, extent and hemodynamic impact of the clot. Over the past years, treatment options for patients with severe PE have expanded substantially. For instance, several new catheter-guided reperfusion therapies have emerged and experience with circulatory mechanical support has increased. Along with the rise of new interventional therapies has come the introduction of expert multidisciplinary pulmonary embolism (EXPERT-PE) care teams, composed of multidisciplinary specialists involved in treating severe acute PE. This model of care provides a platform for rapid decisions on individualized treatment strategies, combining expert opinion from all involved specialties, setting the quality standards for modern local and regional equity PE care, and forming the base for future research in this area. Clinical decisions should be evidence-based where possible, and incorporate the individual patient's and their carer's preferences, values, and priorities, as well as those of the managing clinicians and care team. In this review, we summarize the evidence for the introduction of EXPERT-PE care teams and provide a practical manual for their successful implementation.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145388092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrick Weltler, Paul F Harbich, Achim Burger, Stephan Dobner, Christoph C Kaufmann, Alexander Geppert, Kurt Huber, Edita Pogran
<p><strong>Introduction: </strong>According to real world data only up to 20 % of patients with atherosclerotic cardiovascular disease (ASCVD) are below the recommended LDL-cholesterol (LDL-C) target of < 55mg/dl (<1.4 mmol/L) 1-3 months after the index event. Accordingly, improved strategies for initiating lipid-lowering therapy (LLT) are desired to achieve treatment targets required to further reduce future cardiovascular event rates.</p><p><strong>Materials and methods: </strong>The COR Lipid Registry included patients at very-high cardiovascular (CV) risk presenting for percutaneous coronary intervention (PCI) with acute (ACS) or chronic (CCS) coronary syndrome. Coronary artery disease (CAD) patients with an LDL-C level of >130 mg/dL (equalizing 3.37 mmol/L), or a non-HDL of 160mg/dL (equalizing 4.14 mmol/L) either LLT-naïve or with suboptimal LLT at index hospitalization were enrolled. Based on lipid levels at baseline, these patients were assumed to need triple LLT to achieve their LDL-C target. Baseline characteristics and lipid parameters of all patients were collected at index hospitalization and 2 follow-up visits, after 4-6 and 8-12 weeks, respectively. Initially, in all patients a dual LLT (high-dose, highly effective statin, which means atorvastatin 40mg or 80mg and rosuvastatin 20mg or 40mg, plus ezetimibe) was initiated during the index hospitalization, before PCSK9-inhibitors or bempedoic acid were added, if LDL-C target levels were not met at control visits.</p><p><strong>Results: </strong>In total, 165 very-high-risk patients were included, of which 79 (42.0%) were admitted for CCS, and 109 (58%) for ACS, respectively. At visit 1, 114 (69.1%) patients reached the recommended (ESC/EAS guidelines 2019) lipid goals (LDL-C of < 55 mg/dl; equalising 1.4 mmol/L; or non-HDL-C of 85 mg/dl equalizing 2.2 mmol/<L), while 160 patients (97%) met the target at visit 2. In ACS patients, 74.3% reached the recommended treatment goal (LDL-C or non-HDL-C) at visit 1 and 97.3% at visit 2. In CCS patients, the treatment goal was achieved in 60.8% at visit 1 and 100% at visit 2, respectively. In the LLT-naïve group at admission (n=64), the treatment goal was met in 61.5% of patients at visit 1 and in 96.9% of patients at visit 2, while for LLT-pre-treated patients, the respective data were 76.3% and 100%, respectively.</p><p><strong>Summary: </strong>An optimized LLT-strategy for managing a very-high CV risk patient cohort undergoing PCI, starting with a dual LLT-strategy consisting of a high-dose, highly effective statin plus ezetimibe at the index event followed by addition of a third LL-agent (a PCSK9-inhibitor or bempedoic acid) at follow-up after 4-6 weeks if treatment goal was not reached, was highly effective in achieving LDL-C and non-HDL-C goals. Wider adoption of this strategy may help to significantly improve LDL-C-target levels in real-world populations in very-high risk CAD patients presenting with ACS or CCS for coronary revascularisat
{"title":"The COR Lipid-Registry: The effectiveness of the strike early and strike strong strategy (SES) in patients with high cardiovascular risk.","authors":"Patrick Weltler, Paul F Harbich, Achim Burger, Stephan Dobner, Christoph C Kaufmann, Alexander Geppert, Kurt Huber, Edita Pogran","doi":"10.1093/ehjacc/zuaf137","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf137","url":null,"abstract":"<p><strong>Introduction: </strong>According to real world data only up to 20 % of patients with atherosclerotic cardiovascular disease (ASCVD) are below the recommended LDL-cholesterol (LDL-C) target of < 55mg/dl (<1.4 mmol/L) 1-3 months after the index event. Accordingly, improved strategies for initiating lipid-lowering therapy (LLT) are desired to achieve treatment targets required to further reduce future cardiovascular event rates.</p><p><strong>Materials and methods: </strong>The COR Lipid Registry included patients at very-high cardiovascular (CV) risk presenting for percutaneous coronary intervention (PCI) with acute (ACS) or chronic (CCS) coronary syndrome. Coronary artery disease (CAD) patients with an LDL-C level of >130 mg/dL (equalizing 3.37 mmol/L), or a non-HDL of 160mg/dL (equalizing 4.14 mmol/L) either LLT-naïve or with suboptimal LLT at index hospitalization were enrolled. Based on lipid levels at baseline, these patients were assumed to need triple LLT to achieve their LDL-C target. Baseline characteristics and lipid parameters of all patients were collected at index hospitalization and 2 follow-up visits, after 4-6 and 8-12 weeks, respectively. Initially, in all patients a dual LLT (high-dose, highly effective statin, which means atorvastatin 40mg or 80mg and rosuvastatin 20mg or 40mg, plus ezetimibe) was initiated during the index hospitalization, before PCSK9-inhibitors or bempedoic acid were added, if LDL-C target levels were not met at control visits.</p><p><strong>Results: </strong>In total, 165 very-high-risk patients were included, of which 79 (42.0%) were admitted for CCS, and 109 (58%) for ACS, respectively. At visit 1, 114 (69.1%) patients reached the recommended (ESC/EAS guidelines 2019) lipid goals (LDL-C of < 55 mg/dl; equalising 1.4 mmol/L; or non-HDL-C of 85 mg/dl equalizing 2.2 mmol/<L), while 160 patients (97%) met the target at visit 2. In ACS patients, 74.3% reached the recommended treatment goal (LDL-C or non-HDL-C) at visit 1 and 97.3% at visit 2. In CCS patients, the treatment goal was achieved in 60.8% at visit 1 and 100% at visit 2, respectively. In the LLT-naïve group at admission (n=64), the treatment goal was met in 61.5% of patients at visit 1 and in 96.9% of patients at visit 2, while for LLT-pre-treated patients, the respective data were 76.3% and 100%, respectively.</p><p><strong>Summary: </strong>An optimized LLT-strategy for managing a very-high CV risk patient cohort undergoing PCI, starting with a dual LLT-strategy consisting of a high-dose, highly effective statin plus ezetimibe at the index event followed by addition of a third LL-agent (a PCSK9-inhibitor or bempedoic acid) at follow-up after 4-6 weeks if treatment goal was not reached, was highly effective in achieving LDL-C and non-HDL-C goals. Wider adoption of this strategy may help to significantly improve LDL-C-target levels in real-world populations in very-high risk CAD patients presenting with ACS or CCS for coronary revascularisat","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145388150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tharusan Thevathasan, Michelle Roßberg, Esteban Mery-Fernandez, Janine Pöss, Hannah Schaubroeck, Jacob C Jentzer
Psychological distress, moral injury and burnout are prevalent among intensive care unit (ICU) professionals, impacting individual well-being, team dynamics and patient safety. Structured peer support programs, delivered by trained colleagues rather than mental health professionals, could be implemented as low-threshold, scalable interventions to promote psychological safety and resilience. This review outlines five foundational pillars for implementing peer support in the ICU, including formal program design, training, inclusivity, confidentiality and continuous evaluation. It also addresses practical strategies to overcome cultural and institutional barriers, such as stigma, time constraints and hierarchical norms. Drawing on current evidence and recent unpublished survey data from North American critical care cardiologists, the article provides a practical framework for integrating peer support into ICU culture. Peer support represents a complementary approach to formal mental health services and offers tangible benefits for clinician well-being, retention and quality of care.
{"title":"Fostering Psychological Safety and Resilience in the ICU: Implementing Structured Peer Support.","authors":"Tharusan Thevathasan, Michelle Roßberg, Esteban Mery-Fernandez, Janine Pöss, Hannah Schaubroeck, Jacob C Jentzer","doi":"10.1093/ehjacc/zuaf132","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf132","url":null,"abstract":"<p><p>Psychological distress, moral injury and burnout are prevalent among intensive care unit (ICU) professionals, impacting individual well-being, team dynamics and patient safety. Structured peer support programs, delivered by trained colleagues rather than mental health professionals, could be implemented as low-threshold, scalable interventions to promote psychological safety and resilience. This review outlines five foundational pillars for implementing peer support in the ICU, including formal program design, training, inclusivity, confidentiality and continuous evaluation. It also addresses practical strategies to overcome cultural and institutional barriers, such as stigma, time constraints and hierarchical norms. Drawing on current evidence and recent unpublished survey data from North American critical care cardiologists, the article provides a practical framework for integrating peer support into ICU culture. Peer support represents a complementary approach to formal mental health services and offers tangible benefits for clinician well-being, retention and quality of care.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145299267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mauro Riccardi, Matteo Pagnesi, Carlo M Lombardi, Marco Metra
Acute kidney injury (AKI) is a sudden loss of renal function limited to 7 days with increased basal serum creatinine levels and/or decreased urinary production. AKI is a frequent condition in the intensive care unit (ICU) ranging from 13% to 36% in patients hospitalized with acute heart failure, up to 80% in patients with cardiogenic shock (CS). AKI requiring dialysis is also common (5% to 8%) and can exceed 13% in patients with CS. AKI is consistently associated with increased mortality in both the short-term, especially when dialysis is needed, and the long-term. The aim of this review is to provide an update on step-by-step management, from pharmacological treatment to renal replacement therapy, in patients with severe AKI in ICU patients with fluid overload.
{"title":"Severe acute kidney injury in the intensive care unit: step-to-step management.","authors":"Mauro Riccardi, Matteo Pagnesi, Carlo M Lombardi, Marco Metra","doi":"10.1093/ehjacc/zuaf084","DOIUrl":"10.1093/ehjacc/zuaf084","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is a sudden loss of renal function limited to 7 days with increased basal serum creatinine levels and/or decreased urinary production. AKI is a frequent condition in the intensive care unit (ICU) ranging from 13% to 36% in patients hospitalized with acute heart failure, up to 80% in patients with cardiogenic shock (CS). AKI requiring dialysis is also common (5% to 8%) and can exceed 13% in patients with CS. AKI is consistently associated with increased mortality in both the short-term, especially when dialysis is needed, and the long-term. The aim of this review is to provide an update on step-by-step management, from pharmacological treatment to renal replacement therapy, in patients with severe AKI in ICU patients with fluid overload.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"618-630"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dongju Kim, Dong Hun Lee, Hanna Park, Yong Hun Jung, Byung Kook Lee, Won Young Kim
Aims: Early repolarization patterns (ERPs) are a known risk factor for sudden cardiac death; however, their prognostic significance in cardiac arrest survivors remains unclear. This study aimed to investigate the clinical characteristics and outcomes of ERP in post-cardiac arrest survivors.
Methods and results: This observational cohort study included adult out-of-hospital cardiac arrest survivors (aged ≥18 years) who underwent targeted temperature management at two South Korean tertiary care centres between February 2018 and May 2023. Clinical, electrocardiogram (ECG), and outcome characteristics were compared between patients with and without ERP. Propensity score matching (PSM) was used to minimize confounding, followed by logistic regression analysis. The primary outcome was survival until the hospital discharge. Among the 693 post-resuscitation patients, 127 (18.3%) had ERP. The ERP cohort was characterized by a younger average age (59.0 vs. 64.1 years) and had lower peak levels of troponin I (1.7 vs. 4.5) and creatinine (1.2 vs. 1.4). Multivariable logistic regression analysis revealed that the ERP independently predicted decreased mortality at discharge (odds ratio: 1.68; 95% confidence interval: 1.04-2.72; P = 0.034) after adjusting for potential confounders. However, the difference in achieving favourable neurological outcomes was not statistically significant. These results were consistent within the matched cohort. After matching, groups showed no significant differences in post-resuscitation care variables or adverse events, except for maximum vasopressor doses.
Conclusion: The presence of ERP in post-resuscitation ECG was associated with a greater likelihood of survival until hospital discharge.
{"title":"Early repolarization pattern in post-resuscitation electrocardiogram and outcomes in cardiac arrest survivors: a propensity score matching analysis.","authors":"Dongju Kim, Dong Hun Lee, Hanna Park, Yong Hun Jung, Byung Kook Lee, Won Young Kim","doi":"10.1093/ehjacc/zuaf066","DOIUrl":"10.1093/ehjacc/zuaf066","url":null,"abstract":"<p><strong>Aims: </strong>Early repolarization patterns (ERPs) are a known risk factor for sudden cardiac death; however, their prognostic significance in cardiac arrest survivors remains unclear. This study aimed to investigate the clinical characteristics and outcomes of ERP in post-cardiac arrest survivors.</p><p><strong>Methods and results: </strong>This observational cohort study included adult out-of-hospital cardiac arrest survivors (aged ≥18 years) who underwent targeted temperature management at two South Korean tertiary care centres between February 2018 and May 2023. Clinical, electrocardiogram (ECG), and outcome characteristics were compared between patients with and without ERP. Propensity score matching (PSM) was used to minimize confounding, followed by logistic regression analysis. The primary outcome was survival until the hospital discharge. Among the 693 post-resuscitation patients, 127 (18.3%) had ERP. The ERP cohort was characterized by a younger average age (59.0 vs. 64.1 years) and had lower peak levels of troponin I (1.7 vs. 4.5) and creatinine (1.2 vs. 1.4). Multivariable logistic regression analysis revealed that the ERP independently predicted decreased mortality at discharge (odds ratio: 1.68; 95% confidence interval: 1.04-2.72; P = 0.034) after adjusting for potential confounders. However, the difference in achieving favourable neurological outcomes was not statistically significant. These results were consistent within the matched cohort. After matching, groups showed no significant differences in post-resuscitation care variables or adverse events, except for maximum vasopressor doses.</p><p><strong>Conclusion: </strong>The presence of ERP in post-resuscitation ECG was associated with a greater likelihood of survival until hospital discharge.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"610-617"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143973759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}